Evidence map›Paper›PMID 40610763›Full record

ArticleCommunications medicine2025

Selective identification of polyploid hepatocellular carcinomas with poor prognosis by artificial intelligence-based pathological image recognition.

Takanori Matsuura, Masatoshi Abe, Yoshiyuki Harada, Masahiro Kido, Hajime Nagahara, Yuzo Kodama, Yoshihide Ueda, Eiji Hara, Hirohiko Niioka, Tomonori Matsumoto

Abstract read
In one paragraph

Article in Communications medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Takanori Matsuura *Department of Molecular Biology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.ORCID http://orcid.org/0009-0008-7361-881X
Masatoshi Abe *Faculty of Medicine, Osaka University, Osaka, Japan.ORCID http://orcid.org/0000-0002-4597-6109
Yoshiyuki HaradaDepartment of Molecular Biology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
Masahiro KidoDivision of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.
Hajime NagaharaDepartment of Information and Physical Sciences, Graduate School of Information Science and Technology, Osaka University, Osaka, Japan.
Yuzo KodamaDivision of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
Yoshihide UedaDivision of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
Eiji HaraDepartment of Molecular Biology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.ORCID http://orcid.org/0000-0001-7821-3960
Hirohiko NiiokaInstitute for Datability Science, Osaka University, Osaka, Japan. niioka.hirohiko.136@m.kyushu-u.ac.jp.ORCID http://orcid.org/0000-0003-4542-2883
Tomonori MatsumotoDepartment of Molecular Biology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan. matsumoto.tomonori.fbs@osaka-u.ac.jp.ORCID http://orcid.org/0000-0003-4483-2178

Funding

Japan Agency for Medical Research and Development (AMED) JP22fk0210099Osaka University (OU) Seed Incubation GrantOsaka University (OU) Transdisciplinary Research Project from the Institute for Datability Science
6 · The paper itself

Abstract

backgroundPolyploidy is frequently observed in cancer cells and is closely associated with chromosomal instability, which can lead to cancer progression. Polyploid cancers are more aggressive than diploid cancers, and polyploidy has been shown to be a prognostic marker for hepatocellular carcinoma (HCC). However, polyploidy is challenging to diagnose. Currently, no clinically implementable methods are available for diagnosing polyploidy in cancer.

methodsWe established a method for assessing polyploidization in HCC using deep-learning-based artificial intelligence image recognition models to assess hematoxylin and eosin-stained pathological images. Using 44 HCCs whose ploidy status had been determined by chromosome fluorescence in situ hybridization, we evaluated the ability of our constructed deep learning models to detect HCC ploidy. We then tested the models on an independent group of 169 liver cancers and applied them to a publicly available dataset.

resultsHere we show that our constructed models effectively assess HCC ploidy in a separate cohort and identify a subset with poor prognosis based on the ploidy determinations for 169 HCCs. Our pipeline also identifies HCCs with poor prognosis in the external dataset, with a more significant difference than that for ploidy inferences by genomic analysis. By exploiting the high processing capacity of artificial intelligence, new aspects of polyploid HCC, such as the high prevalence of scirrhous structures, are identified.

conclusionsOur findings suggest that ploidy assessment using artificial intelligence-based pathological image recognition can serve as a novel diagnostic tool for personalized medicine.

Identifiers

PMID40610763
PMCPMC12229707

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.